Ajanta Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code:	532331	NSE Symbol:	AJANTPHARM	P/E :	43.57
ISIN Demat:	INE031B01049	Div & Yield %:	0.8	EPS :	80.61
Book Value:	337.99	Market Cap (Rs. Cr.):	43,890.61	Face Value :	2

Date	Headline
15-Oct-26	Ajanta Pharma to convene a board meeting October 30 to review financial results
07-Oct-26	Ajanta Pharma submitted a regulatory certificate to BSE and NSE for the September quarter
06-Oct-26	Aayush Agrawal pledged Ajanta Pharma shares to secure non-convertible debentures issuance
28-Sep-26	Aayush Agrawal Trust released a pledge on Ajanta Pharma shares following loan repayment
25-Sep-26	Ajanta Pharma will restrict securities trading from October 1, 2026, per SEBI regulations
19-Aug-26	Ravi Agrawal pledged Ajanta Pharma shares for business financing with Aditya Birla Capital
14-Aug-26	Ajanta Pharma promoter released pledge on shares to lenders including Deutsche Investments
30-Jul-26	Ajanta Pharma sets August 5, 2026, as record date for interim dividend
20-Jul-26	Ajanta Pharma to table results
15-Jun-26	Ajanta Pharma to conduct AGM

Company Snapshot